b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">\n        <PMID Version="1">30002801</PMID>\n        <DateRevised>\n            <Year>2019</Year>\n            <Month>11</Month>\n            <Day>20</Day>\n        </DateRevised>\n        <Article PubModel="Electronic-eCollection">\n            <Journal>\n                <ISSN IssnType="Print">2035-3006</ISSN>\n                <JournalIssue CitedMedium="Print">\n                    <Volume>10</Volume>\n                    <Issue>1</Issue>\n                    <PubDate>\n                        <Year>2018</Year>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Mediterranean journal of hematology and infectious diseases</Title>\n                <ISOAbbreviation>Mediterr J Hematol Infect Dis</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Acute Promyelocytic Leukemia in Children: A Single Centre Experience from Turkey.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>e2018045</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.4084/MJHID.2018.045</ELocationID>\n            <Abstract>\n                <AbstractText Label="Background and objectives" NlmCategory="UNASSIGNED">Acute promyelocytic leukemia (APL), is a distinct subtype of acute myeloid leukemia (AML) characterized by a tendency to hemorrhage and excellent response to all-trans retinoic acid (ATRA). In this retrospective study, we aimed to determine the incidence, clinical symptoms, toxicities, and outcome of children with APL in our center.</AbstractText>\n                <AbstractText Label="Methods" NlmCategory="UNASSIGNED">We retrospectively reviewed the medical records of children (age &lt; 18 years) diagnosed with APL in our pediatric hematology department between January 2006-December 2016.</AbstractText>\n                <AbstractText Label="Results" NlmCategory="UNASSIGNED">Pediatric APL represents 20.5% of AML cases in this cohort. Most of the cases presented as classical M3, albeit hypogranular variant was described in 12% of the cohort. Patients with hypogranular variant APL were differed from classical APL by co-expression of CD2 and CD34. About \xc2\xbe of APL patients had hemorrhagic findings at admission or the induction treatment. Severe bleeding manifested as intracranial hemorrhage was present in three patients and intracranial arterial thrombosis was present in one. Six patients showed side effects of ATRA such as pseudotumor cerebri, differentiation syndrome resulting in dilated cardiomyopathy, and pulmonary infiltrates. Five-year overall survival (OS) and early death rate were found to be 82.5% and 12% respectively.</AbstractText>\n                <AbstractText Label="Conclusions" NlmCategory="UNASSIGNED">A high frequency (20.5%) of APL was noted among children with AML in this single-center study. The overall mortality rate was 17.5%. Since the induction death rate was 12% and life-threatening bleeding was the primary problem, awareness and urgent treatment are critical factors to reduce early losses.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Aksu</LastName>\n                    <ForeName>Tekin</ForeName>\n                    <Initials>T</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Pediatric Hematology and Oncology, University of Health Sciences, Ankara Child Health and Diseases Hematology Oncology Training and Research Hospital, Ankara, Turkey.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Fettah</LastName>\n                    <ForeName>Ali</ForeName>\n                    <Initials>A</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Pediatric Hematology and Oncology, University of Health Sciences, Ankara Child Health and Diseases Hematology Oncology Training and Research Hospital, Ankara, Turkey.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Bozkaya</LastName>\n                    <ForeName>\xc4\xb0kbal Ok</ForeName>\n                    <Initials>\xc4\xb0O</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Pediatric Hematology and Oncology, University of Health Sciences, Ankara Child Health and Diseases Hematology Oncology Training and Research Hospital, Ankara, Turkey.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Ba\xc5\x9ftemur</LastName>\n                    <ForeName>Mehmet</ForeName>\n                    <Initials>M</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Pediatric Hematology and Oncology, University of Health Sciences, Ankara Child Health and Diseases Hematology Oncology Training and Research Hospital, Ankara, Turkey.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Kara</LastName>\n                    <ForeName>Abdurrahman</ForeName>\n                    <Initials>A</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Pediatric Hematology and Oncology, University of Health Sciences, Ankara Child Health and Diseases Hematology Oncology Training and Research Hospital, Ankara, Turkey.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>\xc3\x87ulha</LastName>\n                    <ForeName>Vildan Ko\xc5\x9fan</ForeName>\n                    <Initials>VK</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Pediatric Hematology and Oncology, University of Health Sciences, Ankara Child Health and Diseases Hematology Oncology Training and Research Hospital, Ankara, Turkey.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>\xc3\x96zbek</LastName>\n                    <ForeName>Nam\xc4\xb1k Ya\xc5\x9far</ForeName>\n                    <Initials>NY</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Pediatric Hematology and Oncology, University of Health Sciences, Ankara Child Health and Diseases Hematology Oncology Training and Research Hospital, Ankara, Turkey.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Yaral\xc4\xb1</LastName>\n                    <ForeName>Ne\xc5\x9fe</ForeName>\n                    <Initials>N</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Pediatric Hematology and Oncology, University of Health Sciences, Ankara Child Health and Diseases Hematology Oncology Training and Research Hospital, Ankara, Turkey.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2018</Year>\n                <Month>07</Month>\n                <Day>01</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>Italy</Country>\n            <MedlineTA>Mediterr J Hematol Infect Dis</MedlineTA>\n            <NlmUniqueID>101530512</NlmUniqueID>\n            <ISSNLinking>2035-3006</ISSNLinking>\n        </MedlineJournalInfo>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">ATRA toxicity</Keyword>\n            <Keyword MajorTopicYN="N">Acute promyelocytic leukemia</Keyword>\n            <Keyword MajorTopicYN="N">Hypogranular variant APL</Keyword>\n        </KeywordList>\n        <CoiStatement>Competing interests: The authors have declared that no competing interests exist.</CoiStatement>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2018</Year>\n                <Month>01</Month>\n                <Day>20</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2018</Year>\n                <Month>06</Month>\n                <Day>21</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2018</Year>\n                <Month>7</Month>\n                <Day>14</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2018</Year>\n                <Month>7</Month>\n                <Day>14</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2018</Year>\n                <Month>7</Month>\n                <Day>14</Day>\n                <Hour>6</Hour>\n                <Minute>1</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>epublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">30002801</ArticleId>\n            <ArticleId IdType="doi">10.4084/MJHID.2018.045</ArticleId>\n            <ArticleId IdType="pii">mjhid-10-1-e2018045</ArticleId>\n            <ArticleId IdType="pmc">PMC6039079</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Reference>\n                <Citation>J Exp Med. 1990 Dec 1;172(6):1571-5</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">2175343</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Asian Pac J Cancer Prev. 2010;11(5):1393-5</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21198299</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Acta Haematol. 2016;136(1):1-15</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27089249</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Br J Haematol. 2010 May;149(3):399-409</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20230404</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Blood. 2013 Jul 4;122(1):37-43</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23704089</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Curr Oncol Rep. 2000 Nov;2(6):519-23</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">11122887</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Blood. 2010 Mar 4;115(9):1697-702</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20029047</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Blood. 2005 Jul 15;106(2):447-53</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15677559</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Oncol. 2017 Sep 10;35(26):3021-3029</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28767288</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Ann Intern Med. 1985 Oct;103(4):620-5</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">3862359</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Oncol. 2009 Jun 1;27(16):2668-76</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19414681</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Blood. 2000 Aug 15;96(4):1287-96</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">10942370</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Lymphoma Myeloma Leuk. 2016 Mar;16(3):146-51</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26724834</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Blood. 2017 Mar 30;129(13):1763-1767</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28082441</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Semin Oncol. 2008 Aug;35(4):401-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18692690</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mediterr J Hematol Infect Dis. 2015 Jan 01;7(1):e2015012</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25574371</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Blood. 2006 Apr 1;107(7):2627-32</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16352810</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Pol J Pathol. 2012 Mar;63(1):8-17</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22535601</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Ann Hematol. 2017 Sep;96(9):1449-1456</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28597167</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Blood. 1988 Aug;72(2):567-72</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">3165295</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Ann Oncol. 2016 Aug;27(8):1474-81</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27084953</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Pediatr Hematol Oncol. 2010 Nov;32(8):e346-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20881874</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Oncol. 1990 May;8(5):813-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">2185339</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Blood Rev. 2015 Mar;29(2):101-25</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25445717</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Ann Intern Med. 1992 Aug 15;117(4):292-6</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">1637024</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Acta Haematol. 2014;132(3-4):307-12</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25228556</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Br J Haematol. 2016 Aug;174(3):437-43</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27029412</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Blood. 2000 Aug 15;96(4):1247-53</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">10942364</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Haematologica. 2006 Mar;91(3):311-6</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16531253</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Oncol. 2004 Apr 15;22(8):1404-12</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15084614</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Br J Haematol. 2014 Jan;164(1):24-38</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24117210</ArticleId>\n                </ArticleIdList>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'